変形性関節症治療薬の世界市場レポート 2025年

変形性関節症治療薬市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.3％で、122億2,000万米ドルに成長します。予測期間の成長は、肥満率の上昇、治療法の進歩、認知度と診断の向上、疾患修飾性変形性関節症治療薬（DMOADs）の開発、研究に対する政府および民間の資金提供に起因しています。予測期間における主な動向としては、個別化医療への注目の高まり、再生療法の登場、疼痛管理の選択肢の拡大、政府・規制当局の支援、新興市場における需要の高まりなどが挙げられます。

スポーツ傷害の増加は、今後の変形性関節症治療薬市場の成長を牽引すると予想されます。スポーツ傷害とは、スポーツ活動中に受けた損傷や危害のことで、軽度から重度まであり、身体のさまざまな部位に影響を及ぼします。スポーツ傷害の増加は、主にスポーツへの参加の増加と、これらの活動の強度と競合の増加によるものです。変形性関節症治療薬は、このような傷害による関節の変性を経験したアスリートの疼痛管理、炎症の軽減、関節機能の改善に使用されます。例えば、米国を拠点とする健康と安全に特化した非営利団体であるNational Safety Councilは、2022年にスポーツやレクリエーションによる怪我が12％増加したと報告しています。その結果、スポーツ傷害の増加が変形性関節症治療薬市場の成長に拍車をかけています。

変形性関節症治療薬市場の主要企業は、変形性関節症の組織再生の進歩など、革新的なソリューションの開発に注力しています。変形性関節症における組織再生は、損傷した軟骨や関節組織を修復または置換することで機能を回復し、痛みを緩和します。例えば、2023年5月、米国の政府機関であるAdvanced Research Projects Agency for Health（ARPA-H）は、Novel Innovations for Tissue Regeneration in Osteoarthritis（変形性関節症における組織再生のための新規イノベーション）プログラム（NITRO）を開始しました。このプログラムは、胚発生時に活性化されるのと同様の生物学的経路を利用して軟骨の修復を促す最先端の注射療法を生み出すことを目的としています。NITROの重要な点は、研究チーム間の協力的なマルチモーダル・アプローチと、関節環境を再現する「ジョイント・オン・ア・チップ」プラットフォームなどの高度な検査技術の使用です。このイニシアチブは、変形性関節症の根本的な原因に対処する再生ソリューションを開発し、より効果的な長期的治療を提供することを目指しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界変形性関節症治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の変形性関節症治療薬市場：成長率分析
• 世界の変形性関節症治療薬市場の実績：規模と成長, 2019-2024
• 世界の変形性関節症治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界変形性関節症治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の変形性関節症治療薬市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 関節内補充療法剤
• 非ステロイド性抗炎症薬
• 鎮痛剤
• コルチコステロイド
• その他の薬物の種類
• 世界の変形性関節症治療薬市場解剖学による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 変形性膝関節症
• 変形性股関節症
• 手の変形性関節症
• その他の解剖学
• 世界の変形性関節症治療薬市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非経口経路
• 局所経路
• 経口経路
• 世界の変形性関節症治療薬市場：販売チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 処方薬
• 市販薬
• 世界の変形性関節症治療薬市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• その他の用途
• 世界の変形性関節症治療薬市場関節内補充療法剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒアルロン酸注射
• 単回注射製品
• マルチインジェクション製品
• 世界の変形性関節症治療薬市場非ステロイド性抗炎症薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口NSAIDs
• 局所NSAIDs
• COX-2阻害剤
• 世界の変形性関節症治療薬市場鎮痛剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• オピオイド鎮痛薬
• 非オピオイド鎮痛剤
• 局所鎮痛剤
• 世界の変形性関節症治療薬市場コルチコステロイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射用コルチコステロイド
• 経口コルチコステロイド
• 関節内コルチコステロイド
• 世界の変形性関節症治療薬市場、その他の薬剤タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疾患修飾性変形性関節症薬（DMOAD）
• 多血小板血漿療法
• 幹細胞療法

第7章 地域別・国別分析

• 世界の変形性関節症治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の変形性関節症治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 変形性関節症治療薬市場：競合情勢
• 変形性関節症治療薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• Bristol-Myers Squibb Company
• Novartis AG
• GlaxoSmithKline plc
• Medtronic plc
• Eli Lilly and Company
• Gilead Sciences Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Daiichi Sankyo Company Limited
• Zimmer Biomet Holdings Inc.
• Horizon Therapeutics plc
• Taisho Pharmaceutical Co. Ltd.
• Ferring Pharmaceuticals
• Galapagos NV

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 変形性関節症治療薬市場2029：新たな機会を提供する国
• 変形性関節症治療薬市場2029：新たな機会を提供するセグメント
• 変形性関節症治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Osteoarthritis therapeutics encompass a range of medical treatments and interventions aimed at managing and alleviating the symptoms of osteoarthritis, a degenerative joint disease marked by the deterioration of cartilage and underlying bone. These treatments include medications, physical therapies, lifestyle changes, and, in some cases, surgical procedures. The main objectives of osteoarthritis therapeutics are to reduce pain, enhance joint function, and improve the quality of life for those affected by the condition.

Key drug types for osteoarthritis management include viscosupplementation agents, nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, corticosteroids, and others. Viscosupplementation agents are injected directly into the joint to provide lubrication and cushioning, which helps relieve pain and improve mobility. The condition can affect various joints, such as the knee, hip, and hand, and treatments can be administered through different routes, including parenteral, topical, and oral. Sales channels for these therapeutics include prescription and over-the-counter drugs, with end-users ranging from hospital pharmacies to retail pharmacies and other outlets.

The osteoarthritis therapeutics market research report is one of a series of new reports from The Business Research Company that provides osteoarthritis therapeutics market statistics, including osteoarthritis therapeutics industry global market size, regional shares, competitors with a osteoarthritis therapeutics market share, detailed osteoarthritis therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the osteoarthritis therapeutics industry. This osteoarthritis therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The osteoarthritis therapeutics market size has grown strongly in recent years. It will grow from $8.17 $ billion in 2024 to $8.87 $ billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to an aging population, advancements in drug delivery systems, increasing awareness and diagnosis, development of novel therapies, and rising obesity rates.

The osteoarthritis therapeutics market size is expected to see strong growth in the next few years. It will grow to $12.22 $ billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising obesity rates, advancements in treatment modalities, increasing awareness and diagnosis, development of disease-modifying osteoarthritis drugs (DMOADs), and government and private funding for research. Major trends in the forecast period include increasing focus on personalized medicine, the emergence of regenerative therapies, the expansion of pain management options, government and regulatory support, and rising demand in emerging markets.

The increase in sports injuries is expected to drive the growth of the osteoarthritis therapeutics market in the future. A sports injury refers to any damage or harm sustained during athletic activities, ranging from mild to severe, and affecting various parts of the body. The rise in sports injuries is primarily due to growing participation in sports and the increasing intensity and competitiveness of these activities. Osteoarthritis therapeutics are used to manage pain, reduce inflammation, and improve joint function in athletes experiencing joint degeneration from such injuries. For example, in 2022, the National Safety Council, a US-based nonprofit organization focused on health and safety, reported a 12% increase in sports and recreational injuries. As a result, the rising number of sports injuries is fueling the growth of the osteoarthritis therapeutics market.

Leading companies in the osteoarthritis therapeutics market are concentrating on developing innovative solutions, such as advancements in tissue regeneration for osteoarthritis. Tissue regeneration in osteoarthritis involves repairing or replacing damaged cartilage and joint tissues to restore function and alleviate pain. For instance, in May 2023, the Advanced Research Projects Agency for Health (ARPA-H), a US-based government agency, launched the Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program. This program aims to create cutting-edge injectable therapies that stimulate cartilage repair by utilizing biological pathways similar to those active during embryonic development. A key aspect of NITRO is its collaborative, multimodal approach among research teams and the use of advanced testing techniques, such as "joint-on-a-chip" platforms that replicate joint environments. This initiative seeks to develop regenerative solutions that address the underlying causes of osteoarthritis, offering more effective long-term treatments.

In April 2022, Juniper Biologics Pte Ltd, a pharmaceutical company based in Singapore, acquired the licensing rights for TG-C LD (TissueGene-C low dose) from Kolon Life Science for $600 million. This acquisition positions Juniper Biologics as a leader in cell-mediated gene therapies for knee osteoarthritis, addressing a significant unmet medical need affecting around 300 million patients in the Asia Pacific, Middle East, and Africa regions. Kolon Life Science Inc., based in South Korea, specializes in osteoarthritis therapeutics.

Major companies operating in the osteoarthritis therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Zimmer Biomet Holdings Inc., Horizon Therapeutics plc, Taisho Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, Galapagos NV, Bioventus LLC, Flexion Therapeutics Inc., Anika Therapeutics Inc., Seikagaku Corporation, Samumed LLC, Orthogen AG, Kolon Life Science Inc.

North America was the largest region in the osteoarthritis therapeutics market in 2023. The regions covered in the osteoarthritis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the osteoarthritis therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The osteoarthritis therapeutics market consists of revenues earned by entities by providing services such as exercises and therapies, diagnostic services, and pain management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The osteoarthritis therapeutics market also includes sales of pain relievers, corticosteroids, hyaluronic acid injections, and assistive devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Osteoarthritis Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on osteoarthritis therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for osteoarthritis therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The osteoarthritis therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) Drug Type: Viscosupplementation Agents; Nonsteroidal Anti-inflammatory Drugs; Analgesics; Corticosteroids; Other Drug Types
• 2) By Anatomy: Knee Osteoarthritis; Hip Osteoarthritis; Hand Osteoarthritis; Other Anatomies
• 3) By Route Of Administration: Parenteral Route; Topical Route; Oral Route
• 4) By Sales Channel: Prescription Drugs; Over-the-Counter Drugs
• 5) By End-use: Hospital Pharmacies; Retail Pharmacies; Other End-uses
• Subsegments:
• 1) Viscosupplementation Agents: Hyaluronic Acid Injections; Single-Injection Products; Multi-Injection Products
• 2) Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs; Topical NSAIDs; COX-2 Inhibitors
• 3) Analgesics: Opioid Analgesics; Non-Opioid Analgesics; Topical Analgesics
• 4) Corticosteroids: Injectable Corticosteroids; Oral Corticosteroids; Intra-Articular Corticosteroids
• 5) Other Drug Types: Disease-Modifying Osteoarthritis Drugs (DMOADs); Platelet-Rich Plasma Therapy; Stem Cell Therapy
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Osteoarthritis Therapeutics Market Characteristics

3. Osteoarthritis Therapeutics Market Trends And Strategies

4. Osteoarthritis Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Osteoarthritis Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Osteoarthritis Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Osteoarthritis Therapeutics Market Growth Rate Analysis
• 5.4. Global Osteoarthritis Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Osteoarthritis Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Osteoarthritis Therapeutics Total Addressable Market (TAM)

6. Osteoarthritis Therapeutics Market Segmentation

• 6.1. Global Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viscosupplementation Agents
• Nonsteroidal Anti-inflammatory Drugs
• Analgesics
• Corticosteroids
• Other Drug Types
• 6.2. Global Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Knee Osteoarthritis
• Hip Osteoarthritis
• Hand Osteoarthritis
• Other Anatomies
• 6.3. Global Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral Route
• Topical Route
• Oral Route
• 6.4. Global Osteoarthritis Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription Drugs
• Over-the-Counter Drugs
• 6.5. Global Osteoarthritis Therapeutics Market, Segmentation By End-use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Other End-uses
• 6.6. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Viscosupplementation Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hyaluronic Acid Injections
• Single-Injection Products
• Multi-Injection Products
• 6.7. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Nonsteroidal Anti-inflammatory Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral NSAIDs
• Topical NSAIDs
• COX-2 Inhibitors
• 6.8. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Opioid Analgesics
• Non-Opioid Analgesics
• Topical Analgesics
• 6.9. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Corticosteroids
• Oral Corticosteroids
• Intra-Articular Corticosteroids
• 6.10. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disease-Modifying Osteoarthritis Drugs (DMOADs)
• Platelet-Rich Plasma Therapy
• Stem Cell Therapy

7. Osteoarthritis Therapeutics Market Regional And Country Analysis

• 7.1. Global Osteoarthritis Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Osteoarthritis Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Osteoarthritis Therapeutics Market

• 8.1. Asia-Pacific Osteoarthritis Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Osteoarthritis Therapeutics Market

• 9.1. China Osteoarthritis Therapeutics Market Overview
• 9.2. China Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Osteoarthritis Therapeutics Market

• 10.1. India Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Osteoarthritis Therapeutics Market

• 11.1. Japan Osteoarthritis Therapeutics Market Overview
• 11.2. Japan Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Osteoarthritis Therapeutics Market

• 12.1. Australia Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Osteoarthritis Therapeutics Market

• 13.1. Indonesia Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Osteoarthritis Therapeutics Market

• 14.1. South Korea Osteoarthritis Therapeutics Market Overview
• 14.2. South Korea Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Osteoarthritis Therapeutics Market

• 15.1. Western Europe Osteoarthritis Therapeutics Market Overview
• 15.2. Western Europe Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Osteoarthritis Therapeutics Market

• 16.1. UK Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Osteoarthritis Therapeutics Market

• 17.1. Germany Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Osteoarthritis Therapeutics Market

• 18.1. France Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Osteoarthritis Therapeutics Market

• 19.1. Italy Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Osteoarthritis Therapeutics Market

• 20.1. Spain Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Osteoarthritis Therapeutics Market

• 21.1. Eastern Europe Osteoarthritis Therapeutics Market Overview
• 21.2. Eastern Europe Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Osteoarthritis Therapeutics Market

• 22.1. Russia Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Osteoarthritis Therapeutics Market

• 23.1. North America Osteoarthritis Therapeutics Market Overview
• 23.2. North America Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Osteoarthritis Therapeutics Market

• 24.1. USA Osteoarthritis Therapeutics Market Overview
• 24.2. USA Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Osteoarthritis Therapeutics Market

• 25.1. Canada Osteoarthritis Therapeutics Market Overview
• 25.2. Canada Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Osteoarthritis Therapeutics Market

• 26.1. South America Osteoarthritis Therapeutics Market Overview
• 26.2. South America Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Osteoarthritis Therapeutics Market

• 27.1. Brazil Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Osteoarthritis Therapeutics Market

• 28.1. Middle East Osteoarthritis Therapeutics Market Overview
• 28.2. Middle East Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Osteoarthritis Therapeutics Market

• 29.1. Africa Osteoarthritis Therapeutics Market Overview
• 29.2. Africa Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Osteoarthritis Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Osteoarthritis Therapeutics Market Competitive Landscape
• 30.2. Osteoarthritis Therapeutics Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Osteoarthritis Therapeutics Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol-Myers Squibb Company
• 31.3. Novartis AG
• 31.4. GlaxoSmithKline plc
• 31.5. Medtronic plc
• 31.6. Eli Lilly and Company
• 31.7. Gilead Sciences Inc.
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Regeneron Pharmaceuticals Inc.
• 31.10. Daiichi Sankyo Company Limited
• 31.11. Zimmer Biomet Holdings Inc.
• 31.12. Horizon Therapeutics plc
• 31.13. Taisho Pharmaceutical Co. Ltd.
• 31.14. Ferring Pharmaceuticals
• 31.15. Galapagos NV

32. Global Osteoarthritis Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Osteoarthritis Therapeutics Market

34. Recent Developments In The Osteoarthritis Therapeutics Market

35. Osteoarthritis Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 Osteoarthritis Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Osteoarthritis Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Osteoarthritis Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer